Hermetica Superfood Encyclopedia
The Short Answer
Palmitoylethanolamide (PEA) is an endogenous fatty acid amide that modulates inflammatory responses through peroxisome proliferator-activated receptor alpha (PPAR-α) activation. PEA provides analgesic and neuroprotective effects by reducing neuroinflammation and supporting endocannabinoid system function.
CategoryExtract & Compound
GroupEndocannabinoid
Evidence LevelStrong
Primary Keywordpalmitoylethanolamide benefits
Synergy Pairings4
Health Benefits
Supports pain relief by modulating inflammatory responses, reducing chronic pain symptoms. This makes it a natural alternative to conventional painkillers. - Enhances neuroprotection and supports brain health by reducing neuroinflammation, which can improve cognitive function and protect against neurodegenerative diseases. - Boosts immune function by modulating the immune response, enhancing the body's ability to fight infections. - Reduces symptoms of depression and anxiety by influencing endocannabinoid receptors, which regulate mood and stress. - Supports joint health by reducing inflammation and pain, improving mobility and quality of life. - Enhances skin health by reducing inflammation and promoting healing, leading to clearer, healthier skin. - Promotes cardiovascular health by reducing inflammation in blood vessels, improving circulation and reducing the risk of heart disease.
Origin & History
Palmitoylethanolamide (PEA) is a naturally occurring fatty acid amide found in foods like egg yolk and soy lecithin. It is synthesized in the body and can also be extracted from these sources for supplemental use.
“Discovered in the mid-20th century, PEA has been used in Europe for its anti-inflammatory properties. It gained popularity due to its role in modulating the endocannabinoid system.”Traditional Medicine
Scientific Research
Studies include randomized controlled trials (RCTs) and meta-analyses indicating its efficacy in pain management and inflammation reduction. Preclinical studies support its neuroprotective properties.
Preparation & Dosage
Typical dosage ranges from 300 mg to 1,200 mg per day, divided into two or three doses. Consult a healthcare provider before use.
Nutritional Profile
- Contains fatty acid amide that interacts with cannabinoid receptors.
- Non-psychoactive and naturally occurring in the body.
- Often used in micronized form for better absorption.
How It Works
Mechanism of Action
PEA primarily activates peroxisome proliferator-activated receptor alpha (PPAR-α), which regulates inflammatory gene expression and reduces production of pro-inflammatory cytokines like TNF-α and IL-1β. It also modulates mast cell degranulation and enhances anandamide signaling through entourage effects. Additionally, PEA influences transient receptor potential vanilloid 1 (TRPV1) channels and nuclear factor kappa B (NF-κB) pathways to provide analgesic effects.
Clinical Evidence
Multiple randomized controlled trials involving over 2,000 participants demonstrate PEA's efficacy for chronic pain conditions. Studies show 300-1200mg daily reduces pain scores by 30-50% in neuropathic pain, osteoarthritis, and fibromyalgia over 4-12 weeks. Double-blind trials in carpal tunnel syndrome and sciatic pain reveal significant improvements compared to placebo. However, most studies are relatively small (50-300 participants) and longer-term safety data remains limited.
Safety & Interactions
PEA demonstrates excellent safety with minimal side effects in clinical trials, occasionally causing mild gastrointestinal upset in sensitive individuals. No significant drug interactions have been reported, though theoretical interactions may exist with anticoagulant medications due to potential effects on platelet aggregation. Pregnant and breastfeeding women should avoid PEA due to insufficient safety data. Individuals with liver disease should consult healthcare providers before use, as PPAR-α activation may affect hepatic metabolism.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the typical dosage of palmitoylethanolamide for pain relief?
Clinical studies typically use 300-600mg of PEA twice daily for chronic pain conditions. Higher doses up to 1200mg daily have been used safely in some trials, with micronized or ultra-micronized formulations showing enhanced bioavailability.
How long does it take for PEA to work for pain relief?
Most clinical studies show initial pain reduction within 2-4 weeks of consistent PEA supplementation. Maximum benefits typically occur after 8-12 weeks of continuous use, as PEA works by gradually reducing inflammatory processes rather than providing immediate analgesic effects.
Can PEA be taken with other pain medications?
PEA appears safe to combine with most conventional pain medications including NSAIDs and acetaminophen, with no reported interactions in clinical studies. Some research suggests PEA may enhance the effectiveness of other analgesics, potentially allowing for reduced dosages of conventional painkillers.
Is palmitoylethanolamide the same as CBD or other cannabinoids?
PEA is an endocannabinoid-like compound but differs from CBD and THC in structure and mechanism. While CBD primarily targets CB1 and CB2 receptors, PEA works through PPAR-α activation and doesn't directly bind to cannabinoid receptors, making it non-psychoactive.
What conditions have been studied with PEA supplementation?
Clinical research supports PEA use for diabetic neuropathy, carpal tunnel syndrome, osteoarthritis, fibromyalgia, and chronic low back pain. Emerging studies investigate its effects on eczema, endometriosis, and inflammatory bowel conditions, though more research is needed for these applications.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
